The mTOR signaling pathway, as a classic targeted molecule for the systemic therapy of RCC, has also been shown to promote and regulate the proliferation and invasion of cancer cells and is regulated by ECHS1, a key enzyme in fatty acid metabolism [31]. Here, MTOR is linked to cancer.